SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096336
Filing Date
2024-08-13
Accepted
2024-08-13 16:31:34
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20240630.htm   iXBRL 10-Q 2821214
2 EX-10.1 stro-ex10_1.htm EX-10.1 123298
3 EX-31.1 stro-ex31_1.htm EX-31.1 14873
4 EX-31.2 stro-ex31_2.htm EX-31.2 14984
5 EX-32.1 stro-ex32_1.htm EX-32.1 7254
6 EX-32.2 stro-ex32_2.htm EX-32.2 7284
  Complete submission text file 0000950170-24-096336.txt   10629272

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240630.xsd EX-101.SCH 1431781
71 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240630_htm.xml XML 1975017
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 241202202
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)